SGC

Business Context and Reporting Period

Company: Superior Uniform Group, Inc. (formerly Superior Surgical Mfg. Co., Inc.)
Reporting Period: Fiscal year ended December 31, 2001
Business Overview: The Company manufactures and sells uniforms, service apparel, and related accessories for medical, industrial, commercial, and public safety markets. Approximately 95% of revenue is derived from uniforms and service apparel. The Company operates as a single segment with no significant distinct lines of business. It markets itself as a "stock house," maintaining substantial inventories to fulfill orders within 1-2 weeks.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 8.6% to $153.2 million, attributed to an economic slowdown causing customers to postpone or cancel orders.
• Cost of Goods Sold (COGS): COGS as a percentage of sales increased slightly to 65.7% (from 65.5%) due to reduced production levels and less efficient overhead absorption, partially offset by offshore production transitions.
• Selling & Administrative Expenses: Increased as a percentage of sales to 26.6% (from 26.2%) primarily due to lower sales volume, despite significant staffing reductions. A one-time vendor settlement gain of $1.68 million reduced expenses in Q2 2001.
• Debt Reduction: Long-term debt decreased significantly by approximately $16 million (54% reduction) as the Company paid down borrowings under its revolving credit agreement and retired a 5-year term loan in June 2001.
• Cash Flow Improvement: Operating cash flow turned positive, providing $24.3 million, compared to a utilization of $2.6 million in 2000. This was driven by a $9.8 million reduction in inventory and a $6.8 million decrease in accounts receivable.

Guidance, Outlook, and Risks

• Outlook: Management anticipates continuing dividend payments and potential share repurchases as financial conditions allow. The Company believes liquidity is satisfactory to fund operations and planned expansion for 2002.
• Dividends: Cash dividends of $0.54 per share were paid in 2001. Approximately $10.26 million of retained earnings were available for dividends as of year-end, subject to debt covenants.
• Capital Expenditures: Capital expenditures were approximately $1.35 million in 2001, down from $2.83 million in 2000.
• Risks and Contingencies:
  • Economic Conditions: Results are sensitive to general economic conditions and changes in the healthcare, resort, and commercial industries.
  • Competition: Faces competition from national, regional, and local firms regarding product development, styling, and pricing.
  • Customer Concentration: No single customer accounted for more than 5% of 2001 sales.
  • Interest Rate Risk: The Company has variable rate debt tied to LIBOR. A 1% increase in rates would increase interest expense by approximately $42,000. An interest rate swap hedges a portion of this risk.
  • Accounting Changes: The Company will adopt FAS No. 142 (Goodwill) and FAS No. 144 (Impairment) in 2002, ceasing goodwill amortization and adopting an impairment-only approach.

Investor Verification Checklist

• Order Backlog: Verify the trend in order backlog, which decreased to approximately $5.2 million as of February 16, 2002, from $6.6 million the prior year.
• Inventory Levels: Confirm the sustainability of the $9.8 million inventory reduction, which was a primary driver of 2001 operating cash flow.
• Debt Covenants: Review compliance with restrictive covenants regarding tangible net worth ($65.1 million required), working capital ratio (2.5:1), and fixed charges coverage (2.5:1).
• Vendor Settlement: Assess the impact of the $4.0 million vendor settlement (resulting in a $1.68 million gain) on the comparability of 2001 operating expenses.
• Offshore Production: Monitor the transition of production to offshore contractors and its effect on future COGS and margins.